Drug discovery platform Exscientia sets terms for $275 million US IPO

Robert Marcus
Sep 27, 2021

Related news

Oct 17
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

The Source Code of Life

Aug 11
,
0221
AI
Cleantech
Healthcare
Investment
Life Science
Press

Major venture capital investment in European life sciences will fuel occupier market

Dec 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Pharma giant collabs with CMU in AI academy launch

Sep 22
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Intuit launches venture arm to invest in startups with innovation for small businesses, consumers

Oct 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Microsoft’s next moves: Biz dev and strategy leader Christopher Young is focusing on these key areas

Nov 7
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

CapitalVX: A machine learning model for startup selection and exit prediction

Sep 21
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Interest in sustainable investing is at an all-time high

Apr 7
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

The Virtuous Cycle: Innovation and Investment

Mar 26
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

VC Firms Have Long Backed AI. Now, They Are Using It.

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Intelligence Artificielle : l'UM6P signe un partenariat avec la start-up ALPHA10X

Feb 1
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding

Mar 29
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

3 Myths About Women Working in Tech, Busted